发债方面，1月4日，国家金融监督管理总局北京监管局接连发布两则批复，分别同意中华联合人寿 保险股份有限公司和长城人寿保险股份有限公司在全国银行间债券市场公开发行资本补充债券，合计发 行规模不超过15.7亿元。1月9日，国家金融监督管理总局深圳监管局发布批复，同意招商仁和人寿在全 国银行间债券市场公开发行规模不超过23亿元的永续债。 本报记者 杨笑寒 近日，国家金融监督管理总局深圳监管局批复同意招商局仁和人寿保险股份有限公司（以下简 称"招商仁和人寿"）在全国银行间债券市场公开发行无固定期限资本债券（以下简称"永续债"），发行 规模不超过23亿元（含，下同）。 近年来，险企资本补充规模持续维持在高位。据《证券日报》记者统计，2025年，险企增资发债规 模合计达1454.72亿元。 受访专家表示，险企"补血"规模较大，主要受利率下行、偿二代二期工程实施等因素影响。 规模较2024年微增 增资和发债是险企补充资本的两种主要方式。开年以来，国家金融监督管理总局发布多项批复，同 意险企增加注册资本或发行债券。 补充渠道日益多元 值得注意的是，在险企补充资本的进程中，永续债作为新型工具，呈现发行规模持续攀升的趋势。 具体 ...

增资和发债是险企补充资本的两种主要方式。开年以来，国家金融监督管理总局发布多项批复，同意险 企增加注册资本或发行债券。 发债方面，1月4日，国家金融监督管理总局北京监管局接连发布两则批复，分别同意中华联合人寿保险 股份有限公司和长城人寿保险股份有限公司在全国银行间债券市场公开发行资本补充债券，合计发行规 模不超过15.7亿元。1月9日，国家金融监督管理总局深圳监管局发布批复，同意招商仁和人寿在全国银 行间债券市场公开发行规模不超过23亿元的永续债。 增资方面，1月7日，国家金融监督管理总局上海监管局发布批复，同意安盛环球再保险（上海）有限公 司增加注册资本3417.9万元。 今年以来，险企密集"补血"的趋势延续。近年来，在利率下行和偿二代二期工程实施的背景下，险企偿 付能力承压，"补血"规模持续处于高位。 近日，国家金融监督管理总局深圳监管局批复同意招商局仁和人寿保险股份有限公司（以下简称"招商 仁和人寿"）在全国银行间债券市场公开发行无固定期限资本债券（以下简称"永续债"），发行规模不 超过23亿元（含，下同）。 近年来，险企资本补充规模持续维持在高位。据《证券日报》记者统计，2025年，险企增资发债规模合 ...

Core Viewpoint - The Chinese insurance industry is experiencing a new wave of capital replenishment, with approximately 20 insurance companies announcing capital increase plans as of December 2025, driven by stricter regulatory requirements and market challenges [1][14]. Group 1: Industry Capital Increase Overview - Nearly 20 insurance companies have disclosed capital increase plans or received approvals since 2025, with 12 already approved [1][15]. - Companies that have completed or received approval for capital increases include major players such as Ping An Life, Taikang Pension, and Huatai Insurance [1][3]. - The capital increase actions in 2025 are characterized by large scale and concentration, with Ping An Life proposing a record capital increase plan of nearly 20 billion yuan [3][16]. Group 2: Regulatory and Market Drivers - The upcoming end of the transition period for the "Insurance Company Solvency Supervision Rules (II)" has led to stricter requirements for solvency ratios, particularly core solvency ratios, putting pressure on some insurance companies to meet standards [1][4]. - The implementation of the new insurance contract standard (IFRS 17) and the ongoing low interest rate environment have posed challenges to the profitability and internal capital accumulation capabilities of insurance companies [1][4][17]. - The dual drivers of regulatory pressure and market challenges are pushing the industry from passive capital replenishment to proactive capital management [5][18]. Group 3: Motivations for Capital Increases - The motivations for the capital increase plans can be categorized into three main types: capital reserve demands from growth-oriented insurers, equity optimization and solvency consolidation, and further business development [6][18]. - Growth-oriented insurers like Hengqin Life are seeking to build capital reserves to address increasing capital consumption due to expanding business scale [20]. - Established companies like Huatai Insurance are addressing long-standing equity issues and solvency pressures through capital increases, aiming to improve their financial stability and operational capabilities [21][22]. Group 4: Future Outlook and Industry Trends - The trend of capital increases reflects a recognition of the long-term value of the Chinese insurance industry, with foreign and state-owned investors playing significant roles [28]. - The ability to convert the replenished capital into operational efficiency and risk management will be crucial for sustainable development in the industry [28]. - As industry differentiation intensifies, companies with weak capital strength may face greater pressure, while those with clear strategies and solid foundations are likely to seize opportunities for high-quality growth [28].

Core Viewpoint - The insurance industry is witnessing a significant shift towards dividend insurance products as the main offerings for the "opening red" season in 2026, driven by market conditions and regulatory guidance [1][3][6]. Group 1: Product Launches - Xinhua Insurance launched its flagship product, the "Shengshi Glory Celebration Edition" whole life insurance (dividend type) on November 6 [1]. - Ping An Life introduced two dividend insurance products: "Ping An Yuxiang Jinyue (2026)" whole life insurance and "Ping An Yuxiang Jinyue" annuity insurance on November 8 [1]. - China Life launched the "Xinhongfu Pension Annuity Insurance" (dividend type) prior to these announcements [1]. - Taikang Life released the "Xinxiang Shijia 2026" insurance product on September 29, utilizing a dual mechanism of "fixed benefits + floating dividends" to mitigate market volatility risks [1]. Group 2: Market Trends - The structure of "opening red" products has significantly changed, with dividend insurance becoming the absolute market leader, especially among large insurance companies [2]. - The differentiation among products is becoming more pronounced, with features such as extended age limits for policyholders and integrated healthcare services [2]. - The "Shengshi Glory Celebration Edition" from Xinhua Insurance combines traditional product sales with a comprehensive product system focusing on retirement wealth, health care, and disability care [2]. Group 3: Industry Insights - The shift towards dividend insurance is attributed to three main factors: alleviating pressure from interest rate differentials, increasing attractiveness of floating yield products, and alignment with long-term investment characteristics of insurance funds [3]. - The sales performance of dividend insurance is expected to exceed earlier forecasts, potentially leading to resilient growth in the liability side of insurance companies in 2026 [3]. Group 4: Distribution Channels - The "reporting and operation integration" policy has led to tighter regulation of individual insurance channels, resulting in a notable decline in new individual premium income since September [4]. - In contrast, the bancassurance channel has shown strong growth, with significant increases in new business value (NBV) for major insurers [5][6]. - The bancassurance channel is expected to play a crucial role in the 2026 "opening red" season, driven by strong demand for stable wealth management products [6]. Group 5: Strategic Recommendations - Insurers are advised to balance business scale and value, enhance sales channel construction, and optimize product design and information disclosure to adapt to the current market environment [6][7]. - The integration of "product + service" is identified as a core strategy for enhancing the competitiveness of "opening red" products among leading insurers [7].

Core Viewpoint - The article discusses the implementation of the second phase of the solvency regulation (偿二代二期) for insurance companies in China, focusing on the calculation and significance of future policy earnings and remaining margins as key indicators of the operational status of life insurance companies [1]. Group 1: Future Policy Earnings and Remaining Margins - The future policy earnings, introduced under the second phase of solvency regulation, can be derived using specific formulas, which help in understanding the remaining margins of profitable life insurance companies [2][3]. - The difference between accounting reserves and solvency reserves is termed ACCIF, representing the contribution of existing policies to actual capital. For most small and medium-sized life insurance companies, future policy earnings equate to ACCIF [3]. - By the end of 2024, only 27 life insurance companies are expected to have reported three consecutive years of profitability under tax standards, with specific companies like 人保寿险 failing to meet this criterion [5]. Group 2: Analysis of Remaining Margins - The article identifies four main reasons for a decline in future policy earnings: high proportion of participating insurance, increased comprehensive premiums, lower continuation rates for high future earnings products, and adjustments in actuarial assumptions that lower accounting reserves [9]. - The remaining margin's calculation under the current CGAAP is locked, and changes in the present value of amortization carriers are minimally affected by the 750-day curve changes [10]. - The operational deviations, excluding policy cancellations, do not impact the remaining margins of existing policies, while mortality rate deviations have a negligible effect [12]. Group 3: Impact of Surrender Rates on Remaining Margins - Different companies have varying assumptions regarding surrender rates for mainstream products, significantly affecting their remaining margins [14]. - For example, a comparison of surrender rates of 1% versus 5% shows that the remaining margins can be nearly doubled under lower surrender rate assumptions [15]. - Some companies have accumulated considerable remaining margins through the sale of low-priced long-term critical illness insurance, but their claims ratios have exceeded pricing assumptions, leading to potential future losses [16]. Group 4: Remaining Margins Data - The remaining margins for major life insurance companies are presented, showing fluctuations from 2022 to 2024. For instance, 平安人寿's remaining margin is projected to decrease from 8,944 million in 2022 to 7,890 million in 2024, a decline of 1,054 million [17][19].

Core Insights - The report highlights the performance of non-listed life insurance companies in terms of investment returns for the first half of 2025, indicating a positive trend in investment yields across the sector [1][6]. Investment Returns - A total of 59 non-listed life insurance companies reported their investment returns, with 6 companies achieving an investment yield exceeding 3% [2][5]. - The top performers in terms of investment yield include: - Junlong Life Insurance Co., Ltd. at 4.67% - Beijing Life Insurance Co., Ltd. at 3.65% - Lian Life Insurance Co., Ltd. at 3.22% [2][3]. - In terms of comprehensive investment returns, 12 companies surpassed a 3% yield, with Changcheng Life Insurance leading at 6.82% [4][5]. Trends in Investment Strategy - The insurance sector is adapting to new accounting standards and regulatory frameworks, which are influencing investment decisions [7][9]. - There is a noticeable shift towards long-term asset allocation, with a preference for high-rated bonds and equity investments, particularly in the banking sector [7][8]. - The number of equity stakes taken by insurance companies has increased significantly, with 22 announcements made by 11 companies by August 8, 2025, surpassing the total for the entire previous year [7][8]. Regulatory Environment - Recent policies aim to support long-term investments, including increasing the proportion of equity investments by insurance companies [9][10]. - The industry has seen a reduction in the preset interest rates for insurance products, which is expected to alleviate pressure on bond allocations [9][10]. Future Outlook - The ability to match assets and liabilities is becoming crucial for insurance companies to navigate interest rate fluctuations and ensure sustainable growth [10].

Core Viewpoint - The issuance of perpetual bonds by Taiping Life Insurance Co., Ltd. is part of a broader trend among insurance companies to raise capital through bond issuance, driven by increased solvency requirements, lower market interest rates, and the need for business expansion [1][2]. Group 1: Bond Issuance Trends - Taiping Life successfully issued perpetual bonds worth 9 billion yuan with a coupon rate of 2.40% [2]. - As of March 20, 2023, insurance companies have issued a total of 36.6 billion yuan in capital supplementary bonds and perpetual bonds this year, compared to none in the same period last year [2][4]. - Five out of eight insurance companies that issued bonds this year opted for perpetual bonds, totaling 32.7 billion yuan [4]. Group 2: Factors Driving Bond Issuance - The need for capital replenishment is driven by four main factors: higher capital adequacy requirements due to regulatory changes, lower market interest rates allowing for cost-effective refinancing, competitive market pressures necessitating sufficient capital for business expansion, and the need to enhance risk resilience and market competitiveness [2][3]. - The trend of "redeeming old bonds and issuing new ones" is prevalent, allowing companies to lower financing costs and improve financial performance [3]. Group 3: Future Outlook - The demand for capital replenishment among insurance companies is expected to remain high, particularly for smaller firms, which may explore new capital-raising tools such as preferred shares and convertible bonds [5]. - Regulatory support is anticipated to encourage insurance companies, especially smaller ones, to broaden their capital replenishment channels [5].

Core Insights - The speed of capital replenishment among insurance companies has significantly increased recently, with major issuances of perpetual bonds [1][2] - The total issuance of perpetual bonds by insurance companies this year has reached 457 billion yuan, surpassing the total of 359 billion yuan for the entire previous year [2] Group 1: Recent Issuances - Taiping Life successfully issued 9 billion yuan of perpetual bonds with a coupon rate of 2.40% [1] - Eight insurance companies, including Taiping Life, Ping An Life, and Taikang Life, have issued capital replenishment bonds and perpetual bonds totaling 36.6 billion yuan [1] - Among these, five companies issued perpetual bonds, amounting to a total of 32.7 billion yuan [1] Group 2: Market Trends - The issuance of perpetual bonds has been driven by higher capital adequacy requirements under the second phase of the solvency regime, prompting companies to replenish capital [2] - Current market interest rates are relatively low, allowing insurance companies to finance at a lower cost [2] - The coupon rates for perpetual bonds issued in 2023 range from 2.20% to 2.48%, while those for 2024 are between 2.20% and 2.50% [2]

Group 1 - The core viewpoint of the articles highlights the increasing capital needs of insurance companies in China, driven by stricter regulatory requirements and the need to support business growth [1][2][3] - As of June 20, 2023, the Beijing Regulatory Bureau approved capital increases for Zhongyou Life and China United Life, with Zhongyou Life's capital rising from 28.663 billion to 32.643 billion yuan and China United Life's from 2.9 billion to 4.1 billion yuan [1] - In 2023, insurance companies have collectively raised 69.213 billion yuan through capital increases and bond issuance, marking a 95% year-on-year increase [1] Group 2 - At least six insurance companies have been approved for capital increases this year, totaling 8.853 billion yuan, including Ping An Life and Guolian Life [1] - Twelve insurance companies have issued capital supplement bonds or perpetual bonds, with a total issuance scale of 60.36 billion yuan [1] - The second phase of the solvency regulatory framework has led to a decline in solvency adequacy ratios for many insurance companies, necessitating external capital supplementation through shareholder investments and bond issuance [2] Group 3 - New capital supplementation methods are emerging, allowing insurance companies to diversify their capital-raising strategies and enhance flexibility [3] - Regulatory adjustments, such as extending the transition period for solvency regulations and reducing risk factors for stock investments, aim to optimize capital structures for insurance companies [3] - Insurance companies, especially smaller ones, are encouraged to leverage regulatory transition policies and seek external funding while adjusting their business structures to reduce capital consumption [3]

Core Viewpoint - The article discusses the implementation of the second phase of the solvency regulatory framework in China's insurance industry, focusing on the concept of future policy surplus as a key indicator of a company's future profitability [1][2]. Group 1: Future Policy Surplus - The future policy surplus is introduced under the second phase of solvency regulations and is crucial for assessing a company's future profitability [1]. - The future policy surplus is defined as the difference between accounting reserves and solvency reserves, adjusted for potential tax provisions and cash value guarantees [2]. - As of 2024, the future policy surplus for 66 insurance companies is projected to be 2.26 trillion, accounting for 8.8% of total assets, a decrease of approximately 150 billion from the end of 2022 [14]. Group 2: Impact of Accounting Standards - Starting in 2023, insurance companies began implementing the new accounting standard IFRS 17, which affects how insurance reserves are reported [3]. - The article highlights the importance of consistency in reporting deferred tax liabilities (DTL) and actual capital across different accounting standards [7][8]. - Companies that do not maintain consistency in their reporting may face challenges in validating their solvency reports [9]. Group 3: Analysis of Companies - The article provides a detailed analysis of various insurance companies, noting that the future policy surplus varies significantly among them, with some companies like AIA Life exceeding 15% of total assets [14]. - The article identifies that companies with a high proportion of participating insurance products tend to have lower future policy surplus compared to traditional insurance products [16]. - The future policy surplus for major players like China Life and Ping An has shown a noticeable decline, attributed to their historical focus on participating insurance products [15]. Group 4: Factors Influencing Future Policy Surplus - The decline in future policy surplus can be attributed to several factors, including a high proportion of participating insurance, adjustments in risk premiums, and changes in actuarial assumptions [19]. - Conversely, an increase in future policy surplus may result from a lower proportion of participating insurance and the successful generation of new business [19][22]. - The article emphasizes that the future policy surplus is a critical indicator but does not fully reflect a company's overall asset-liability management (ALM) status [16].